TG Therapeutics | TGTX - Ebitda

Prezzo Delle Azioni
30.36
Cambio Giornaliero
0.32 1.07%
Mensile
2.81%
Annuale
-27.52%
Q1 Previsione
27.12




Ebitda Cambiamento Data
AbbVie USD 3.52B 828M 2025-09
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 5.14B 775M 2025-12
Ardelyx USD 6.02M 447K 2025-12
Arrowhead Research USD 64.2M 223.53M 2025-09
Bayer EUR 1.97B 457M 2025-12
Biogen USD 573.2M 253.7M 2025-12
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Curis USD -12.3M 231K 2023-09
Gilead Sciences USD 4.03B 628M 2025-09
Infinity Pharmaceuticals USD -10.01M 1.39M 2023-06
J&J USD 9.52B 389M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Novartis USD 4.77B 1.11B 2025-12
Novavax USD 19.36M 190.79M 2025-12
PTC Therapeutics USD 20.63M 53.74M 2025-09
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
TG Therapeutics USD 32.69M 5M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09